MESA LABORATORIES INC /CO (MLAB)

128.93 +0.34% (+0.44)

Over 1M: +27.9%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

100 110 120 130
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q2 '22 — Operating Income: 4.2M Q3 '22 — Operating Income: -2.5M Q4 '22 — Operating Income: -110K Q1 '23 — Operating Income: -4.6M Q2 '23 — Operating Income: 4M Q3 '23 — Operating Income: 3.4M Q4 '23 — Operating Income: 517K Q1 '24 — Operating Income: -664K Q2 '24 — Operating Income: -60K Q3 '24 — Operating Income: -67K Q4 '24 — Operating Income: -271.3M Q1 '25 — Operating Income: 5.6M Q2 '25 — Operating Income: 3.5M Q3 '25 — Operating Income: 5.8M Q4 '25 — Operating Income: 1.5M Q1 '26 — Operating Income: 3.1M Q2 '26 — Operating Income: 4.7M Q3 '26 — Operating Income: 8M Q4 '26 — Operating Income: 2.7M Q1 '27 — Operating Income: 7M -240M -180M -120M -60M 0 60M
Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27
Operating Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.9
OE margin 14.6%
ROIC 7.9%
Accruals -11.7%
OCF / EBIT 2.5×
FCF margin 21.2%
Gross margin 64.2%
OCF margin 22.3%
ROA 1.6%
ROCE 6.2%
ROE 3.6%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.2
RPO / sales 0.058×
Segment HHI 0.3 HHI
RPO growth —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.1
ND/EBITDA —
Debt payback 0.67 yr
F-score 8.0 pts
Net debt / Eq 0.19×
Debt / Eq 0.35×
Cash / Debt 0.46×
Quick ratio 1.3×
Payout 52.7%
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.7
Sales/sh Y/Y +0.37%
EBIT CAGR +80.1%
EBIT Y/Y +62.6%
EPS CAGR 4Y +36.4%
Div. growth +1.6%
Sales Q/Q +1%
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.